This is the first demonstration that activation of PPARα ligand suppresses expression and activity of survival kinases in breast cancer cells, thus providing novel insight into the nuclear receptor mediated signaling pathways involving highly metastatic breast cancer. Here, PPARA is linked to breast carcinoma.